Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001615774-15-003321
Filing Date
2015-11-16
Accepted
2015-11-16 16:32:22
Documents
1
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 5 s102196_form5.html 5  
1 5 s102196_form5.xml 5 6892
  Complete submission text file 0001615774-15-003321.txt   8364
Mailing Address 61 MOULTON ST CAMBRIDGE MA 02138
Business Address
MISSLING CHRISTOPHER U (Reporting) CIK: 0001196573 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-37606 | Film No.: 151235575

Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Issuer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 8731 Services-Commercial Physical & Biological Research